aztreonam has been researched along with Hematologic Neoplasms in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hobson, CA | 1 |
| Bonacorsi, S | 1 |
| Fahd, M | 1 |
| Baruchel, A | 1 |
| Cointe, A | 1 |
| Poey, N | 1 |
| Jacquier, H | 1 |
| Doit, C | 1 |
| Monjault, A | 1 |
| Tenaillon, O | 1 |
| Birgy, A | 1 |
1 other study available for aztreonam and Hematologic Neoplasms
| Article | Year |
|---|---|
Successful Treatment of Bacteremia Due to NDM-1-Producing
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamases; Ceftazidime; Ce | 2019 |